San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Genome Pioneer Venter Joins President for Unveiling of Precision Medicine Initiative

San Diego’s genome pioneer J. Craig Venter, co-founder and CEO of Human Longevity Inc., was among leaders in the field of genomics on hand at the White House on Friday as President Barack Obama outlined his Precision Medicine Initiative.

Mirati Therapeutics Announces Pricing of Public Offering

Mirati Therapeutics Inc., a company developing medicines for targeted oncology, announced the pricing of an underwritten public offering at $45 million.

Tease photo

Qualcomm Life, Roche Group to Collaborate

Qualcomm Life Inc., the mobile health-focused subsidiary of Qualcomm Inc., announced a collaboration with the Roche Group to innovate remote monitoring and management of patients with chronic diseases.

BioNano Genomics Reports Raising $68.5 Million in Financing

San Diego-based BioNano Genomics Inc., a genome-mapping device company, has raised $68.5 million in financing, according to a recent filing with the Securities and Exchange Commission.

Youngevity Raises $5 Million in Equity, Debt Financing

Youngevity International Inc., a global direct marketer of nutritional and lifestyle products and producer of gourmet coffees, has raised $5 million in equity and debt financing, according to a recent filing with the Securities and Exchange Commission.

Illumina Reports Fourth-Quarter Net Income of $153.3 Million

San Diego-based Illumina Inc. reported fourth-quarter net income of $153.3 million, or $1.03 per share, up from $80.7 million, or $0.56 per share, last year.

DexCom Gets FDA Approval for Glucose-Monitoring Mobile App

DexCom Inc., a San Diego-based medical device company, announced that it has received U.S. Food and Drug Administration approval for a continuous glucose-monitoring system with data-sharing capabilities.

Aspyrian Therapeutics Raises $8.45 Million in Equity Financing

Aspyrian Therapeutics Inc., a San Diego-based biotechnology startup, has raised $8.45 million in equity financing, according to a recent filing with the Securities and Exchange Commission.

Region’s Genomics Industry Could See Big Financial Boost

President Obama’s State of the Union address Jan. 20 teased the federal launch of an initiative that could provide a huge financial boost to San Diego’s genomics industry.

Cypher Genomics, Sequenom to Partner on Developing Prenatal Tests

Two San Diego companies, Cypher Genomics Inc. and Sequenom Inc., announced an agreement to further develop next-generation noninvasive prenatal tests.

Tease photo

Weight-Loss Balloon Expands Options for Those With Lower BMIs

HEALTH: Financing Should Help With U.S. Approval Process

The founding team of multibillion-dollar medical device maker DexCom Inc. is working on a new project that may offer an alternative to stomach-stapling surgeries.

Tease photo

Telehealth Pod Brings Care to Campuses

MEDICINE: Kaiser Part Of National Pilot Project

Kaiser Permanente San Diego is testing a high-tech telehealth station that allows patients to see a doctor without ever leaving work.

TRACON Pharmaceuticals Announces Terms for IPO

TRACON Pharmaceuticals Inc., which is developing antibodies to treat cancer, age-related macular degeneration and fibrotic diseases, announced terms for its IPO.

Tease photo

ResMed's Q2 Income of $91.2 Million Surpasses Expectations

ResMed Inc. reported fiscal second-quarter net income of $91.2 million on Thursday.

Tease photo

Otonomy Files for Proposed Follow-On Public Offering

San Diego-based Otonomy Inc. has filed for a proposed follow-on public offering of $75 million of its common stock.